Seizing on the Trump administrations deregulation drive, corporate lobbyists are pushing to override state laws on ingredient-disclosure rules and warning labels, including landmark California legislation on potential cancer risks.
DebugScreen: mobile
{
"author": {
"name": "Lauren Coleman Lochner Bloomberg",
"webUrl": "/author/profile/lauren-coleman-lochner-bloomberg/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2017/11/17/californias-famed-cancer-warnings-imperiled-by-fed/",
"title": "California's famed cancer warnings imperiled by federal push",
"byline": " Lauren Coleman-Lochner, Bloomberg ",
"kicker": "",
"prettyDate": "November 17, 2017",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/lauren-coleman-lochner-bloomberg/",
"name": "Lauren Coleman-Lochner, Bloomberg"
}
],
"kickerNode": [],
"summary": "Seizing on the Trump administrations deregulation drive, corporate lobbyists are pushing to override state laws on ingredient-disclosure rules and warning labels, including landmark California legislation on potential cancer risks.",
"body": null
}
]
}
}